APA (7th ed.) Citation

D, M., R, G., EL, B., S, C., JR, C., F, F., & S, B. (2022). Re-routing Metabolism by the Mitochondrial Pyruvate Carrier Inhibitor MSDC-0160 Attenuates Neurodegeneration in a Rat Model of Parkinson's Disease. Molecular neurobiology, 59(10), 6170. https://doi.org/10.1007/s12035-022-02962-9

Chicago Style (17th ed.) Citation

D, Mallet, Goutaudier R, Barbier EL, Carnicella S, Colca JR, Fauvelle F, and Boulet S. "Re-routing Metabolism by the Mitochondrial Pyruvate Carrier Inhibitor MSDC-0160 Attenuates Neurodegeneration in a Rat Model of Parkinson's Disease." Molecular Neurobiology 59, no. 10 (2022): 6170. https://doi.org/10.1007/s12035-022-02962-9.

MLA (9th ed.) Citation

D, Mallet, et al. "Re-routing Metabolism by the Mitochondrial Pyruvate Carrier Inhibitor MSDC-0160 Attenuates Neurodegeneration in a Rat Model of Parkinson's Disease." Molecular Neurobiology, vol. 59, no. 10, 2022, p. 6170, https://doi.org/10.1007/s12035-022-02962-9.